Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11476
PUT
Annovis Bio
ANVS
$77.1M
| $111K | ﹤0.01% |
73,700
-113,700
| -61% | -$348K |
|
|
NOTV
11477
PUT
DELISTED
Inotiv
NOTV
| $111K | ﹤0.01% |
50,000
-17,800
| -26% | -$65.3K |
|
11478
TELA Bio
TELA
$29.2M
| $110K | ﹤0.01% |
+90,515
| New | +$223K |
|
|
LUCK
11479
CALL
Lucky Strike Entertainment
LUCK
$853M
| $110K | ﹤0.01% |
+11,300
| New | +$118K |
|
11480
PUT
Sensus Healthcare
SRTS
$55.5M
| $110K | ﹤0.01% |
+23,300
| New | +$136K |
|
11481
BRC Group Holdings
RILY
$286M
| $110K | ﹤0.01% |
28,371
+3,075
| +12% | +$13.9K |
|
11482
IT Tech Packaging
ITP
$3.06M
| $110K | ﹤0.01% |
400,096
+39,408
| +11% | +$14.4K |
|
11483
Biomea Fusion
BMEA
$122M
| $110K | ﹤0.01% |
51,445
+31,259
| +155% | +$106K |
|
|
PMF
11484
DELISTED
PIMCO Municipal Income Fund
PMF
| $109K | ﹤0.01% |
12,382
+98
| +0.8% | +$884 |
|
11485
PUT
1-800-Flowers.com
FLWS
$240M
| $109K | ﹤0.01% |
+18,500
| New | +$136K |
|
|
NSLR
11486
PUT
Neostellar Capital Corp
NSLR
$272M
| $109K | ﹤0.01% |
21,900
-190,700
| -90% | -$1.11M |
|
11487
Quetta Acquisition Corp
QETA
$44M
| $109K | ﹤0.01% |
10,169
-48,660
| -83% | -$517K |
|
11488
Veritone
VERI
$82.4M
| $109K | ﹤0.01% |
46,708
-184,246
| -80% | -$535K |
|
|
MFM
11489
Aberdeen Municipal Income Fund
MFM
$222M
| $109K | ﹤0.01% |
20,479
-26
| -0.1% | -$141 |
|
11490
Beamr Imaging
BMR
$19.9M
| $109K | ﹤0.01% |
+49,333
| New | +$157K |
|
11491
PUT
Abeona Therapeutics
ABEO
$345M
| $108K | ﹤0.01% |
+22,700
| New | +$123K |
|
11492
PUT
Hyliion Holdings
HYLN
$609M
| $108K | ﹤0.01% |
77,100
-100,500
| -57% | -$199K |
|
|
BRW
11493
Saba Capital Income & Opportunities Fund
BRW
$329M
| $108K | ﹤0.01% |
13,860
| – | – |
|
11494
CALL
Arq
ARQ
$96.1M
| $107K | ﹤0.01% |
25,700
-27,600
| -52% | -$157K |
|
|
SOND
11495
DELISTED
Sonder
SOND
| $107K | ﹤0.01% |
+53,369
| New | +$151K |
|
11496
Lineage Cell Therapeutics
LCTX
$293M
| $107K | ﹤0.01% |
236,109
+172,795
| +273% | +$101K |
|
|
11497
PUT
Arq
ARQ
$96.1M
| $106K | ﹤0.01% |
+25,500
| New | +$145K |
|
11498
PepGen
PEPG
$213M
| $106K | ﹤0.01% |
+75,608
| New | +$156K |
|
|
PRT
11499
PermRock Royalty Trust Unit
PRT
$27M
| $106K | ﹤0.01% |
24,662
+11,736
| +91% | +$48.7K |
|
|
SEPN
11500
CALL
Septerna Inc
SEPN
$1.89B
| $106K | ﹤0.01% |
+18,300
| New | +$209K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.